看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
- C4 t5 a6 w2 w9 @
+ e. K* r: ?7 _+ i( e0 W [" \; _7 l; `+ r; J. u' M, q
Currently available feasibility data for possible combination strategies. . B" ~7 }) |* \1 p2 t
————————————————————————————————
4 p: P7 h) m2 O& U8 n9 w' rCombination Feasibility according to preliminary data
) H5 E; N- I% k4 ^# c9 h——————————————————————————————————
, s0 @2 Q6 c& A% \, nBevacizumab + sorafenib Yes, reduced dose
& T8 F5 d- t5 `3 N& O3 ?8 lBevacizumab + sunitinib† No
9 |7 S6 [( K: U. x( j" KBevacizumab + temsirolimus Yes ' W- t( q% m8 V% A7 q
Bevacizumab + everolimus Yes
$ K3 l; I1 q% [! V$ ~- E5 JSorafenib + sunitinib ?
7 a) m$ @3 A. D4 KSorafenib + temsirolimus Yes, reduced dose
- S: [) ]- |5 Q' l3 \; PSorafenib + everolimus Yes, reduced dose 4 C# w* n5 ?! i3 @7 z5 J% `5 X7 f
Sunitinib + temsirolimus† No - M$ Y: s0 }0 p; ]9 z
Sunitinib + everolimus ? ) l# n' h0 f# f) M5 o
Temsirolimus + everolimus ? : Q. |* G6 b: K; s7 @ [4 ^8 l* a
————————————————————
* m, E% W2 Z5 ~3 R+ `†Led to US FDA warning.$ x$ _/ u1 |, n0 n8 I* X
?: As yet unattempted combination.8 b3 b: x# J, Y: [
|